SoftBank Vision Fund 2 and Tencent have co-led the intellectual property management platform’s series E round, which reportedly valued it at over $1bn.

The kidney healthcare provider boosted its total funding to more than $220m in a round led by Alphabet's CapitalG subsidiary.

Tencent and Gilead Sciences took part in a round that will fund clinical trials for three of Vaccitech's vaccine product candidates.

OSF Healthcare Ventures contributed to a $102m series D round for Inflammatix, a developer of diagnostics systems for detecting infections.

Fidelity Management & Research has joined new and returning investors to back the website creation platform developer’s latest round at a $10bn valuation.

Novo co-led an $81.5m round for the gene therapy developer that included Sarepta Therapeutics, UCB Ventures, Takeda Ventures and Alexandria Venture Investments.

UF Innovate Ventures has contributed to a series B round for StrideBio, partially based on research into gene therapies at University of Florida.

Tencent co-led a $92.5m round for the corporate expense management tool provider, investing alongside new and returning backers including Eight Roads Ventures.

Alibaba led a $30.8m round that helped the customer service software developer close its third round in the space of less than a year.

Novo Nordisk, Insulet and Mayo Clinic helped the diabetes monitoring technology provider push its overall funding past $100m.